Tom Frinzi
September 30, 2020
Thomas Frinzi is the former Worldwide President, Surgical, Johnson & Johnson Vision business, which includes a broad ophthalmology portfolio across the areas of cataracts and refractive surgery (LASIK). Tom was appointed to his position in February 2017 at the conclusion of Johnson & Johnson’s acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott. Mr. Frinzi joined AMO in January 2016 as Senior Vice President of Abbott Laboratories and President, Abbott Medical Optics.
Prior to joining Abbott, Mr. Frinzi held a number of leadership positions in ophthalmology and medical device companies. Most recently, he served as President and CEO of WaveTec Vision, a developer of surgical systems for eye surgery. He also held senior positions in commercial operations, business development, and sales and marketing at Bausch & Lomb Surgical, Refractec and Johnson & Johnson. In recognition of his leadership, expertise and vision in the field, Mr. Frinzi was awarded the 2015 Ophthalmology Innovation Award by the Ophthalmology Innovation Summit. He earned a bachelor’s degree in political science from the University of Tampa.
Recent Articles
-
Bernie’s Quarterly Update – July 2024
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes
CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes Advanced...
READ MORE -
-
Photo: Bernie Iliakis hosts a lively conversation at ASCRS Boston with
Edward J. Holland M.D. and Terry Kim M.D.
Bernie’s Quarterly Update – April 2024A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE